Subgroup Analysis Of Elderly Patients (Pts) In Alter0303: Anlotinib Hydrochloride As 3rd-Line And Further Line Treatment In Refractory Advanced Nsclc Pts From A Randomized, Double-Blind, Placebo-Controlled Phase Iii Alter0303 Trial
JOURNAL OF CLINICAL ONCOLOGY(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络